Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56M
-
Number of holders
-
218
-
Total 13F shares, excl. options
-
52.8M
-
Shares change
-
+1.01M
-
Total reported value, excl. options
-
$1.33B
-
Value change
-
+$29.3M
-
Put/Call ratio
-
0.28
-
Number of buys
-
99
-
Number of sells
-
-101
-
Price
-
$25.16
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q4 2020
246 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2020.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 218 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.8M shares
of 56M outstanding shares and own 94.28% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.91M shares), VANGUARD GROUP INC (5.3M shares), ARMISTICE CAPITAL, LLC (3.12M shares), MACQUARIE GROUP LTD (2.21M shares), DIMENSIONAL FUND ADVISORS LP (1.93M shares), RENAISSANCE TECHNOLOGIES LLC (1.85M shares), STATE STREET CORP (1.78M shares), GW&K Investment Management, LLC (1.32M shares), FULLER & THALER ASSET MANAGEMENT, INC. (1.3M shares), and ASHFORD CAPITAL MANAGEMENT INC (1.22M shares).
This table shows the top 218 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.